Free Stock Pick From Insider Monkey’s Monthly Newsletter
Our premium monthly newsletter costs $449 annually and features my personal stock picks. To showcase my stock picking ability once or twice a year I share...
Posts Tagged ‘NASDAQ:ASND’
Is Ascendis Pharma A/S (ASND) Going to Burn These Hedge Funds?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings...
Why Ascendis Pharma (ASND) Stock is a Compelling Investment Case
Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Mid-Cap Growth Fund posted a return of 31.64%...
Did Hedge Funds Make The Right Call On Ascendis Pharma A/S (ASND) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings...
Should You Avoid Ascendis Pharma A/S (ASND)?
In this article we will check out the progression of hedge fund sentiment towards Ascendis Pharma A/S (NASDAQ:ASND) and determine whether it is a good...
Hedge Funds Have Never Been This Bullish On Ascendis Pharma A/S (ASND)
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted...
How Did Ascendis Pharma A/S (ASND) Compare Against Hedge Fund Darlings in 2019?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge...
Here’s What Hedge Funds Think About Ascendis Pharma A/S (ASND)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook...
Here’s What Hedge Funds Think About Ascendis Pharma A/S (ASND)
How do we determine whether Ascendis Pharma A/S (NASDAQ:ASND) makes for a good investment at the moment? We analyze the sentiment of a select group of...
Hedge Funds Have Never Been This Bullish On Ascendis Pharma A/S (ASND)
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They...
Wyndham Hotels & Resorts, Inc. (WH): 2019 Sohn Conference New York Recap
Sohn Conference is my favorite hedge fund event. I haven’t missed an event since 2013. This doesn’t mean that every stock pitched at the conference...
Did Hedge Funds Drop The Ball On Ascendis Pharma A/S (ASND) ?
Is Ascendis Pharma A/S (NASDAQ:ASND) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research. We do so because...
Glenview Capital Management’s Stock Pitches At 2018 Sohn Conference
Glenview Capital Management is a New York City-based hedge fund, that was launched 18 years ago by Larry Robbins, who previously worked as a trader for...
Best Stock Pick From The 2018 Sohn Conference (Part II)
Read the beginning of this article here. Nathaniel August recommended a position in Peabody Energy (NYSE:BTU) which “is the largest and least expensive...
What Happened With Light Street’s Glen Kacher’s Best Idea at 2018 Sohn Conference?
It has been almost a year since the last annual Sohn Conference held in New York, and we thought it would be interesting to take a look at how some of...
Mangrove Partners’ Nathaniel August’s Best Idea At 2018 Sohn Conference
Nathaniel August’s Mangrove Partners is known for outperforming the market very often; in the first three years since its launching (2010), the fund...
Sarissa Capital Management Hires New President
Sarissa Capital Management was one of those rare activist hedge funds, which managed to beat the last year’s tough market environment, returning 15....
Should You Buy Ascendis Pharma A/S (ASND)?
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating...
Five Stocks To Buy According To Top Biotech-Focused Funds
Biotechnology is a very interesting industry to invest in, but also very complex. If you are looking for stocks that are most likely to see their value...
13D Filing: OrbiMed Advisors and Ascendis Pharma A/S (ASND)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
Are Hedge Funds On To Something With Ascendis Pharma A/S (ASND) Bullishness?
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down...
Ascendis Pharma (ASND): OrbiMed Advisors Adds More Shares
Samuel Isaly just cannot get enough of Ascendis Pharma A/S (NASDAQ:ASND). According to an amended filing with the Securities and Exchange Commission,...
OrbiMed Advisors Buys Some More Ascendis Pharma (ASND) Shares
Samuel Isaly‘s OrbiMed Advisors has stepped up its interest in Ascendis Pharma A/S (NASDAQ:ASND) as reported in a recently-amended filing with...
Hedge Funds Aren’t Crazy About Ascendis Pharma A/S (ASND) Anymore
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than...
Two Healthcare-Focused Funds Buy More Shares Of 2 Promising Companies, While Activist Cashes Out Of IT Company
You don’t necessarily need millions of dollars to invest like an activist investor such as Carl Icahn or Bill Ackman. Extensive research has concluded...
Jacob Gottlieb Adds To Position In Ascendis Pharma A/S (ASND); Armistice Capital Increases Stake In Demand Media Inc (DMD)
Is it a good time to buy shares of Ascendis Pharma A/S (NASDAQ:ASND)? Jacob Gottlieb thinks so, since his fund, Visium Asset Management, has significantly...
Ascendis Pharma A/S (ASND): Orbimed Advisors Takes Activist Stake in Newly Public Company
Samuel Isaly’s Orbimed Advisors has taken an activist stake in the recently listed Ascendis Pharma A/S (NASDAQ:ASND), an early-stage drug company working...
